Introduction
Kit receptor tyrosine kinase regulates a wide range of functions in various vertebrate cell lineages, including pigment cells, hematopoietic cells, germ cells, gastrointestinal cells, nerve cells, cardiovascular cells, and lung cells (1, 2) . In these cell lineages, stem cells or the immediate descendant of stem cells are strictly dependent on Kit signaling for their survival, proliferation, and differentiation (3) (4) (5) , as are embryonic stem (ES) cells (6) . Kit was originally identified as a feline proto-oncogene. Cancer cells, such as those in gastrointestinal mesenchymal tumors and melanomas, were known to have a gain-of-function mutation in Kit, and anticancer drugs that specifically block Kit signaling are used to treat cancers with Kit mutations (1) .
Kit protein forms a homodimer that binds the Kitl ligand (7) . Heterodimers formed between wild-type and mutant Kit proteins show a considerable reduction of Kit tyrosine kinase activity. This loss of activity is seen in the semidominant inheritance of Kit-locus mutants, in which heterozygous loss-of-function mutations impair melanocyte development to produce white coat spotting (7, 8) .
Kit mRNAs are highly expressed in many tissues, including the developing brain and adult brain (9) (10) (11) ), yet no clear developmental phenotype in the brain resulting from the loss of specific cell types or functions has been detected in Kit-mutant mice. Rather, only either subtle higher-level brain functions were affected, including spatial learning (9) , or relatively minor perturbations to brain structure and biochemistry, including the axon guidance of commissural neurons (12) , and the transduction properties of sensory neurons (13) .
Here, we engineered a conditional loss-of-function Kit mutation into mice that allowed us to induce Kit haploinsufficiency at specific points during development. Using this nongermline induction of Kit haploinsufficiency, we observed severe hypoplasia of the brain not previously reported in mouse Kit mutants. Our findings indicate that Kit expressed in the developing brain is important for proper brain development, and that many neural stem cell lineages are dependent on Kit at certain developmental stages of the brain.
Results

Conditionally induced haploinsufficiency of Kit receptor tyrosine kinase impaired in vitro neural cell differentiation from ES cells.
We generated (129/SvJ × C57BL/6) F1 ES cell clones containing a floxed Kit allele (Kit 2lox/+ ) by conventional homologous gene recombination. In these ES cells, 2 loxP sites flank exon 10 of Kit, which encodes the transmembrane domain. Conditional deletion of exon 10 results in direct splicing of exon 9 to exon 11 and the generation of premature stop codons in exon 11 (14) . After Cre recombination, the allele designated as Kit 1lox/+ resembles the spontaneous Kit W allele in which a mutation in the first nucleotide of Kit receptor tyrosine kinase is highly expressed in the developing mammalian brain, yet little is known about its contribution to neural cell development and function. Here we introduced a brainspecific conditional Kit loss-of-function mutation in mice and observed severe hypoplasia of the central nervous system. This was accompanied by an increase in apoptotic cell death in the early embryonic brain and the gradual loss of the self-renewal capacity of neuronal stem/precursor cells. Figure 1A ) and 80% to 90% of the ES cell-derived colonies contained Tuj1 + neurons. (Figure 1B ). In contrast, the number of colonies containing Tuj1 + neurons from Sox1-Cre; Kit 2lox/+ ES cell lines was significantly reduced in comparison with those from control ES cell lines ( Figure 1B) , and each colony contained a reduced number of Tuj1 + neurons ( Figure 1A Figure 1C and D) . Addition of wild-type recombinant Kitl protein to the Sox1-Cre; Kit 2lox/+ ES cell culture restored the efficiency of neural cell differentiation to that of the control culture (Supplemental Figure 1 ; supplemental material available online with this article; https://doi.org/10.1172/ jci.insight.94385DS1), and this was reversed by the addition of the Kit antagonistic antibody ACK2 (Supplemental Figure 1) Figure 2A , marked by the asterisks), and clear hypoplasia of the head region was evident at E15.5 ( Figure 2B ). Surviving Sox1-Cre; Kit 2lox/+ fetuses at E18.5 showed the same hypoplastic features ( Figure 2C ) including eye defects in some individuals ( Figure 2D ). Penetrance of the brain hypoplasia phenotype in Sox1-Cre; Kit 2lox/+ mice was 92.3% at E12.5 and 100% thereafter (Supplemental Table 1 ). Expression of the endogenous Sox1 gene starts as early as E8.0 (18), and we observed a reduction of Kit mRNA expression in the Kit conditionally knocked out brain to half of that in controls as early as E10.5 to E18.5 ( Figure 2E ). The numbers of neural cells were markedly reduced in the brain and spinal cord of E12.5 Sox1-Cre; Kit 2lox/+ ; Rosa26R-EYFP mice (Supplemental Figure 3A) , and, as expected, cell surface Kit protein per cell decreased in EYFP-expressing neural cells (Supplemental Figure 3B) . E12.5 Sox1-Cre; Kit 2lox/+ embryos showed a marked reduction in the size of the whole brain, including the telencephalon, diencephalon, mesencephalon, metencephalon, and myelencephalon ( Figure 3 , A-C). In particular, the reductions of the telencephalon and myelencephalon were considerable. Drastic hypoplasia of neural cells was also observed in the spinal cord of Sox1-Cre; Kit 2lox/+ embryos ( Figure 3D ). Among the neural tissues that originate from Sox1 + precursors, dorsal root ganglia were found to maintain their absolute size in Sox1-Cre; Kit 2lox/+ embryos ( Figure 3D ). Since only punctate Kit expression was observed in the dorsal root ganglia (9-11), conditional Kit deletion might have only a minor effect on their differentiation. It should be noted that the sizes of nasal chambers ( Figure 3C ), the tongue, and other non-neural organs in Sox1-Cre; Kit 2lox/+ embryos remained comparable with those of the controls. To understand the mechanisms underlying neural hypoplasia in Sox1-Cre; Kit 2lox/+ embryos, we investigated the proliferative characteristics of neural cells in the affected brain regions. In E12.5 embryos, proliferative cells expressing Ki67 and nestin were detected among the ependymal layer cells of the telencephalon both in Sox1-Cre; Kit 2lox/+ and control brains ( Figure 3E ), while Tuj1 + postmitotic neurons in Figure 3E ). A similar reduction in postmitotic neurons was observed in most brain regions including the diencephalon, mesencephalon, metencephalon, and myelencephalon (Supplemental Figure 4) . A comparable number of Ki67 + cells was observed among the ependymal layer cells of the spinal cord in Sox1-Cre; Kit 2lox/+ and control mice ( Figure 3F ). The reduction in the total number of Tuj1 + postmitotic cells seems to be responsible for the drastic reduction in the total size of the spinal cord of Sox1-Cre; Kit 2lox/+ mice (Figure 3F) . Most of the TUNEL + cells were detected in the ependymal layer, but not in the mantle layer ( Figure 3F ). Both in the telencephalon and the spinal cord, TUNEL + cells were found in regions of the ependymal layer in close proximity to the ventricle ( Figure 3 , E and F). The size of the eyes was also reduced in Sox1-Cre; Kit 2lox/+ mice ( Figure 3G ). Ki67 + cells were distributed in the entire developing retina and also in the lens fiber precursor cells both in Sox1-Cre; Kit 2lox/+ and control embryos ( Figure  3G ); however, Tuj1 + neurons were greatly reduced in Sox1-Cre; Kit 2lox/+ retinas. Apoptotic cells were evident within the retina and lens fiber cells ( Figure 3G ). These observations suggest that undifferentiated neural stem cells were maintained and not apoptotic in the E12. + cells were maintained in proportionally similar ratios to those seen in control animals ( Figure 4E ) and apoptotic cells were present at very low levels ( Figure 4E ). These characteristics of Sox1-Cre; Kit 2lox/+ brain structure and head morphology were also observed in E18.5 (Supplemental Figure 5) Figure 7) . We suggest that the antiproliferative effect of Kit haploinsufficiency is limited to the E12.5 developmental stage and that the initial reduction of the proliferative activity could not be compensated for in later developmental stages.
Proliferative embryonic neural stem cells were clearly present in Sox1-Cre-induced Kit haploinsufficient E12.5 embryos. It appears that successive transiently amplifying cells may have been eliminated during the apoptotic event after E12.5 in developing brain and spine. The apoptotic event appeared to be complete by (19, 20) . Sox1 continues to be expressed in activated neural stem or progenitor cells in the adult brain (21, 22) . To test the possibility that neural stem/progenitor cells are among the first cells affected by reduced levels of Kit (induced Kit haploinsufficiency), we generated neurospheres from the brains of Sox1-Cre; Kit 2lox/+ embryos. For E10.5 brains, primary neurospheres were formed with equal frequency from Sox1-Cre; Kit 2lox/+ and control embryos ( Figure 5A ), and the cumulative number of cells constituting neurospheres was also comparable ( Figure 5, B and C) . Although the numbers of primary neurospheres generated from E11.5 brains was also similar for Sox1-Cre; Kit 2lox/+ and control embryos, (Figure 5D ), the cumulative number of cells gradually declined in Sox1-Cre; Kit 2lox/+ neurospheres ( Figure 5 , E and F). For E12.5 and E13.5 brains, the numbers of the primary neurospheres were again similar ( Figure 5, G and J) , and the reduction in Sox1-Cre; Kit 2lox/+ neurosphere proliferation became more substantial ( Figure 5 , H, I, K, and L). Normal proliferation of E10.5 Sox1-Cre; Kit 2lox/+ neurospheres followed by the reduction of their cumulative proliferation in E11.5 or later neurospheres may coincide with the onset of brain hypoplasia detected in E11.5 brains and thereafter (Supplemental Figure 8, A and B) .
We transferred these established neurospheres to a differentiation medium with serum and then colonies containing Tuj1 + or GFAP + cells were counted. While primary neurospheres from E10.5 and 11.5 embryos did not show any significant differences ( Figure 6 , A-D), a significant reduction of colonies containing Tuj1 + or GFAP + cells was observed in Sox1-Cre; Kit 2lox/+ -derived neurospheres from E12.5 and E13.5 brains (Figure 6 , E-H).
We conclude that Kit haploinsufficiency first reduces the long-term self-renewal capacity of induced neurospheres, and then impairs their ability to differentiate into neural cells. This may explain the observed in vivo reduction of differentiated Tuj1 + neurons in Sox1-Cre; Kit 2lox/+ brains.
Discussion
The deleterious effects we see in the differentiation of Kit expression is seen in undifferentiated ES cells and 2-cell embryos (23) , and Kit expression in the brain is detectable from E8.5 (11) . Defects in brain development first became detectable in E12.5 embryos as a hypoplasia of the brain and an increase in TUNEL + cells accompanied by the loss of Tuj1 + differentiated neurons (Figure 3) . To investigate the immediate cause of lethality in Sox1-Cre-induced Kit-haploinsufficient mice, sphere-forming neural stem cells were derived from the embryonic brain. A marked reduction in long-term self-renewal activity was observed in neural stem cells from E11.5, but not E10.5, Sox1-Cre; Kit 2lox/+ brain cells. In E11.5 or later Sox1-Cre; Kit 2lox/+ brain-derived spheres, a decrease in in vitro derivation of neurons and glial cells was seen. These observations demonstrate that Kit plays a crucial role in brain development. Known Kit-dependent functions in neurons involved in spatial learning (24) and the axon guidance of commissural neurons (12) , manifested in germline Kit mutants, seem not to be related to the defective brain development we observe in Sox1-Cre; Kit 2lox/+ embryos. Haploinsufficient embryonic lethality -seen in Dll4 -/+ (25) and Sox17 -/+ (26) mice -has not previously been reported in heterozygous germline Kit mutations. Kit-haploinsufficiency effects are not restricted to neural cells, but are also seen in melanocytes. Unlike neural cells, various germline Kit mutations are known to reduce the viability of the melanocyte cell lineage, which manifests itself as a large white spot in the ventral skin of germline Kit W/+ haploinsufficient mice (8, 27) . The loss of skin melanocytes in Kit mutants was recovered by exogenous Kitl expression (28) . In cases in which Kit haploinsufficiency was induced by the melanocyte lineage-specific Tyr-Cre driver, the total size of the white spot was far more extensive in Figure 9 ). A developmental stage-specific mutation of the Kit regulatory sequence necessary for neural cell-specific expression should have the same haploinsufficient lethal phenotype in the induced and the spontaneous mutant. Naturally, we would not be aware of this type of noninheritable, dominant lethal mutation. It is likely that developmental stage-specific haploinsufficiency is actually taking place to cause embryonic death in general.
A functionally redundant gene product The Kit 1lox allele resulting from the Cre-induced recombination in the Kit 2lox/+ allele is deprived of the transmembrane domain and has extra amino acids at its carboxyl terminus. The Kit W allele has a mutation in intron 10 that, in mast cells, leads to partial exon 10 skipping and termination of the protein at a downstream stop codon, and in bone marrow and brain cells to the in-frame skipping of 3 exons (15 mice are not simply due to differences in the C-termini of the truncated proteins. The administration of recombinant Kitl or anti-Kit antibodies during neural cell development has been shown to influence in vitro outgrowth of neurites and survival of neurons (31), postnatal cerebellum development (32) , induction of long-term potentiation of hippocampal neurons (33) , proliferation of neuronal precursors in the subventricular zone (34), cerebral cortical cell survival (35) , and regeneration of olfactory neurons (36) . We attribute the absence of these phenotypes in Kit W/+ mice to the presence of a functionally redundant Kit-counterpart protein. In summary, our findings provide evidence that Kit signaling is functional in the early development of neural cells, and supports the idea that Kit regulates neural cell development and homeostasis.
Methods
Mice. Kit 2lox/+ mice were generated from Kit 2lox/+ ES cells line as previously described (14) . Rosa26::rtTA; Col1a1::tetO-Cre mice (37, 38) , Sox1-Cre mice (16) , and Rosa26R-EYFP mice (39) were bred with Kit 2lox/+ mice to generate compound transgenic mice. Kit W and Kit Wv mice were obtained from Japan SLC. All mice were housed in standard animal rooms with food and water ad libitum under controlled humidity (50% ± 10%) and temperature (22°C ± 2°C) conditions. The room was illuminated by fluorescent lights that were on from 8:00 AM to 8:00 PM. For embryo timing, vaginal plugs were checked and the day a plug was detected was considered E0. 5 .
Derivation of ES cell lines. The conditional Kit-knockout ES cell line containing doxycycline-inducible Cre alleles was generated from mouse E3.5 embryos that contain conditional Kit-knockout (Kit 2lox ) alleles (14) together with both the Rosa26::rtTA allele and Cola1::tetO-Cre allele (40) as previously described (38 (37) . Briefly, mouse ES cells were cultured under self-renewal conditions on feeder cells in standard ES media (DMEM, Gibco) supplemented with 15% fetal calf serum (FCS, Hyclone), 1× nonessential amino acids, 2 mM L-glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin (all from Gibco), 0.1 mM β-mercaptoethanol (Sigma-Aldrich), and 1,000 U/ml leukemia inhibitory factor (ESGRO, Millipore) on 0.1% gelatin-coated tissue culture dishes.
With minor modifications, the method for the induction of neural lineage was the same as previously described (41, 42) . For differentiation, 1,000 trypsinized ES cells were inoculated on a monolayer of PA6 cells previously seeded on 6-well plates (BD Falcon). ES cells were induced to differentiate in α-minimum essential medium (α-MEM, Invitrogen) supplemented with 10% FCS (EQUITECH-BIO, Inc.). They were maintained in an atmosphere of 5% CO 2 and 95% air at 37°C. Then, 40 pM basic fibroblast growth factor (bFGF, R&D Systems, Inc.) was added to the medium on day 0, and 10 nM dexamethasone (Sigma-Aldrich) was added on day 3. The cultures were also exposed to 20 pM cholera toxin (Wako) from days 0 to 3, and the medium was changed every 3 days. In some experiments, 100 ng/ml recombinant Kitl (BioLegend) and 10 μg/ml rat monoclonal antibody ACK2, which can block Kit function (42, 43) , were added into the culture on the indicated days. In the indicated experiment, Rosa26::rtTA; Col1a1::tetO-Cre; Kit 2lox/+ ES cells were treated with 2 μg/ml doxycycline.
Culture of neurospheres. Pregnant female mice were sacrificed by cervical dislocation, and embryos were quickly put on ice. For neurosphere culture, the brains were collected and dissociated into single-cell suspensions by gentle pipetting. The inner part of the trunk region was collected for genotyping. Primary neurospheres were generated from 1 × 10 4 suspended brain cells/well in a 24-well plate in DMEM/F12 medium (Gibco) supplemented with 1× N2 (Invitrogen), 1× B27 (Invitrogen), 20 ng/ml epidermal growth factor (EGF, R&D Systems, Inc.), and 20 ng/ml bFGF. Primary neurospheres were passaged every 2 days to generate secondary neurospheres and the number of cells constituting the neurospheres was counted before passaging. For the differentiation cultures of the neurospheres, the spheres were individually isolated and 30 neurospheres were inoculated into 6-well plates previously coated with fibronectin/laminin (both from Invitrogen) and cultured in DMEM/F12 supplemented with 1× B27 and 10% FCS (Nichirei Bioscience). Most of the transferred neurospheres attached and formed colonies.
Flow cytometric analysis and cell sorting. Methods for cell preparation and flow cytometric analysis were performed as previously reported in detail (42) . Briefly, cell suspensions of the brain and spinal cord were collected and resuspended in staining medium (SM: PBS containing 3% FCS). The dissociated cells were then blocked with rat anti-mouse Fc gamma receptor (clone 93, BioLegend) on ice for 30 to 40 minutes. After another wash with SM, the cells were stained with phycoerythrin (PE)-conjugated rat anti-mouse CD45 (clone 30-F11, BioLegend) on ice for 30 to 40 minutes, washed, and incubated with allophycocyanin (APC)-conjugated rat anti-mouse c-Kit (clone 2B8, BioLegend) on ice for 30 to 40 minutes. The cells were then washed and resuspended in SM containing 3 μg/ml propidium iodide (PI, Calbiochem) to exclude dead cells. All cell sorting and analyses were performed with a FACSAria dual-laser flow cytometer (BD Biosciences). PI-negative cells were analyzed for CD45-PE and Sox1-Cre; Rosa26R-EYFP. EYFP-positive/ CD45-negative cells were selected and analyzed for Kit-APC fluorescence.
Histology and immunostaining. Pregnant female mice were euthanized with an overdose of sodium pentobarbital (200 mg/kg). The embryos were enucleated and fixed by immersion overnight in 10% formalin in phosphate buffer (pH 7.2). Specimens were dehydrated with ethanol, soaked in xylene, and embedded in paraffin. Serial sections were prepared at a 3-μm thickness using a Leica RM2125RT microtome (Leica RM2125RT, Leica Microsystems Inc.) and stained with hematoxylin and eosin (H&E).
For immunohistochemistry, we used a Mouse-To-Mouse HRP Ready-To-Use Kit (ScyTek Laboratories), according to the manufacturer's protocol, to detect the mouse monoclonal primary antibodies on the sections. All procedures were performed at room temperature. Briefly, after deparaffinization and rehydration in Tris buffer (pH 7.4), specimens were incubated with 1% H 2 O 2 in methanol for 10 minutes to reduce the level of endogenous peroxidase, and then incubated with Super Block for 5 minutes, followed by the Mouse-To-Mouse Block for 30 minutes. After incubation with the primary antibodies for 1 hour at room temperature or at 4°C overnight, the specimens were incubated with UltraTek Anti-Polyvalent (ScyTek Laboratories) for 20 minutes, and then with UltraTek HRP (ScyTek Laboratories) for another 20 minutes. For detection of the goat or rabbit polyclonal primary antibodies, a HISTOFINE Simple Stain Mouse MAX PO Kit (Nichirei BioScience) was used according to the manufacturer's protocol.
For immunocytofluorescence analysis, cells were fixed with 4% paraformaldehyde in PBS for 15 minutes, made permeable by immersion in 0.1% Triton X-100 and 0.5% BSA in PBS for 60 minutes, washed in PBS, and blocked in 0.5% BSA in PBS for 60 minutes. Primary antibodies, diluted in 0.5% BSA in PBS, were then added and allowed to react for 60 minutes at room temperature. After having been washed in PBS, the cells were stained with the secondary antibodies in the same manner. Cells were examined by using an IX-71 fluorescence microscope (Olympus). The number of colonies containing cells stained by each primary antibody was counted in each well. Percentages of marker-positive cells were calculated after counting the total number of colonies in each well.
Antibodies. The following primary antibodies were used in this study: anti-mouse Tuj1 (1:5,000; BabCO, catalog MMS-435P, clone TUJ1), anti-GFAP (1:1,000; Dako-Cytomation, catalog Z0334), anti-mouse nestin (1:500; BD Bioscience, catalog 611659, clone 25), and anti-mouse Ki67 (1:500; Dako-Cytomation, clone TEC-3).
In situ TUNEL method. To detect apoptotic cells, TUNEL staining was performed as previously described (41) . After incubation with 20 μg/ml proteinase K (Sigma-Aldrich), the serial sections used for H&E staining were immersed in terminal deoxynucleotidyl transferase (TDT) buffer (30 mM Trizma base, pH 7.2, 140 mM sodium cacodylate, 1 mM cobalt chloride). TDT and biotinylated dUTP (both from Roche) were diluted in TDT buffer at a concentration of 0.15 e.u./ml and 0.8 nmol/ml, respectively. The solution was placed on the sections and then incubated at 37°C for 60 minutes. The sections were covered with streptavidin peroxidase (DAKO) and stained with DAB as a substrate for the peroxidase. Finally, counterstaining was conducted using Mayer's hematoxylin.
Real-time RT-PCR. Total RNA was prepared using the RNeasy Plus Mini Kit (Qiagen) according to the manufacturer's instructions. The first strand cDNA was synthesized from 1 μg of total RNA using the PrimeScript II 1st strand cDNA Synthesis Kit (Takara) with oligo-dT primers according to the manufacturer's instructions. Real-time PCR was performed with SYBR Premix EX Taq (Takara) using a Thermal Cycler Dice and a Real-Time System Software (Takara).
The relative expression levels of Kit transcripts were compared with the reference gene β-actin using the following mouse-specific primers: Kit exon 2 (forward, 5′-GCCACGTCTCAGCCATCTG-3′; reverse, 5′-GTC-GCCAGCTTCAACTATTAACT-3′), Kit exon 10 (forward, 5′-AAATCCAGGCCCACACTCT-3′; reverse,
